EAM

Eventide Asset Management Portfolio holdings

AUM $5.71B
This Quarter Return
-1.19%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$1.54B
AUM Growth
+$1.54B
Cap. Flow
-$64.7M
Cap. Flow %
-4.21%
Top 10 Hldgs %
28.17%
Holding
136
New
11
Increased
33
Reduced
22
Closed
8

Top Buys

1
WCN icon
Waste Connections
WCN
$13.8M
2
INST
Instructure, Inc.
INST
$13.1M
3
W icon
Wayfair
W
$12.3M
4
SNA icon
Snap-on
SNA
$12M
5
DOOR
MASONITE INTERNATIONAL CORP
DOOR
$6.49M

Top Sells

1
CELG
Celgene Corp
CELG
$19.7M
2
LRCX icon
Lam Research
LRCX
$17.2M
3
WAB icon
Wabtec
WAB
$15.8M
4
SGEN
Seagen Inc. Common Stock
SGEN
$14.5M
5
ORA icon
Ormat Technologies
ORA
$13.4M

Sector Composition

1 Healthcare 33.47%
2 Consumer Discretionary 15.87%
3 Technology 15.54%
4 Industrials 12.46%
5 Utilities 3.95%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CHRS icon
76
Coherus Oncology, Inc. Common Stock
CHRS
$146M
$4.08M 0.27%
145,000
– –
INCY icon
77
Incyte
INCY
$17B
$4.01M 0.26%
40,000
– –
VYGR icon
78
Voyager Therapeutics
VYGR
$204M
$3.82M 0.25%
300,000
– –
ATRC icon
79
AtriCure
ATRC
$1.73B
$3.52M 0.23%
180,000
– –
BLCM
80
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$3.41M 0.22%
+25,000
New +$3.41M
RGEN icon
81
Repligen
RGEN
$6.54B
$3.39M 0.22%
110,000
– –
ALNY icon
82
Alnylam Pharmaceuticals
ALNY
$58.6B
$3.37M 0.22%
90,000
– –
GLPG icon
83
Galapagos
GLPG
$2.06B
$3.34M 0.22%
52,000
– –
EPZM
84
DELISTED
Epizyme, Inc
EPZM
$3.33M 0.22%
275,000
– –
HRTX icon
85
Heron Therapeutics
HRTX
$204M
$2.95M 0.19%
+225,000
New +$2.95M
NGNE icon
86
Neurogene
NGNE
$284M
$2.89M 0.19%
+8,750
New +$2.89M
CDTX icon
87
Cidara Therapeutics
CDTX
$1.61B
$2.75M 0.18%
13,200
– –
KA
88
DELISTED
Kineta, Inc. Common Stock
KA
$2.7M 0.18%
1,571
– –
NTUS
89
DELISTED
Natus Medical Inc
NTUS
$2.61M 0.17%
75,000
– –
AGTC
90
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.61M 0.17%
279,100
– –
VRTX icon
91
Vertex Pharmaceuticals
VRTX
$102B
$2.55M 0.17%
34,600
– –
TGTX icon
92
TG Therapeutics
TGTX
$5.03B
$2.5M 0.16%
537,600
– –
TTPH
93
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$2.42M 0.16%
30,000
– –
GBT
94
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.38M 0.16%
165,000
– –
NVAX icon
95
Novavax
NVAX
$1.2B
$1.83M 0.12%
72,485
-36,500
-33% -$920K
SYRS
96
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.82M 0.12%
15,000
– –
JUNO
97
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.7M 0.11%
90,000
– –
CTMX icon
98
CytomX Therapeutics
CTMX
$350M
$1.65M 0.11%
150,000
– –
SEP
99
DELISTED
Spectra Engy Parters Lp
SEP
$1.6M 0.1%
35,000
+3,000
+9% +$137K
HTGC icon
100
Hercules Capital
HTGC
$3.51B
$1.5M 0.1%
106,000
+27,000
+34% +$381K
2 3
4
5 6